ClinVar Miner

Submissions for variant NM_000548.5(TSC2):c.1762G>T (p.Glu588Ter)

dbSNP: rs1596336374
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001050047 SCV001214134 pathogenic Tuberous sclerosis 2 2019-11-18 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Glu588*) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This variant has not been reported in the literature in individuals with TSC2-related conditions.
Ambry Genetics RCV002409428 SCV002716768 pathogenic Hereditary cancer-predisposing syndrome 2018-12-14 criteria provided, single submitter clinical testing The p.E588* pathogenic mutation (also known as c.1762G>T), located in coding exon 16 of the TSC2 gene, results from a G to T substitution at nucleotide position 1762. This changes the amino acid from a glutamic acid to a stop codon within coding exon 16. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.